AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 52(4), 1995, pp. 322-324
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jelinek, T.
Right arrow Articles by Loscher, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jelinek, T.
Right arrow Articles by Loscher, T.

Long-Term Efficacy of Primaquine in the Treatment of Vivax Malaria in Nonimmune Travelers

T. Jelinek, H. D. Nothdurft, F. Von Sonnenburg AND T. Loscher
Department of Infectious Diseases and Tropical Medicine, University of Munich, Munich, Germany

Fifty-six travelers presenting with vivax malaria to a German travel clinic were followed regularly for at least 18 months between 1984 and 1992 to investigate the long-term efficacy of primaquine in nonimmune patients without reinfection. All received a standard treatment of 15 mg of primaquine a day for 14 days following an initial total dose of 1,500 mg of chloroquine (base) given over a 48-hr period. None of the patients visited countries endemic for malaria during the period of observation. In seven patients (12.5%), relapses were confirmed microscopically by detection of malaria parasites in blood films. The frequency of relapses varied between one and four per patient and these occurred between 60 and 252 days after treatment. Four of these seven patients had acquired infection in Papua New Guinea or eastern Indonesia, while only five (10.2%) of the remaining 49 patients without relapses had traveled to these areas prior to referral (P < 0.01).




This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
J. K. BAIRD
A RARE GLIMPSE AT THE EFFICACY OF PRIMAQUINE
Am J Trop Med Hyg, February 1, 2007; 76(2): 201 - 202.
[Full Text] [PDF]

Home page
 JAMAHome page
L. H. Chen, M. E. Wilson, and P. Schlagenhauf
Prevention of malaria in long-term travelers.
JAMA, November 8, 2006; 296(18): 2234 - 2244.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
D. R. HILL, J. K. BAIRD, M. E. PARISE, L. S. LEWIS, E. T. RYAN, and A. J. MAGILL
PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I.
Am J Trop Med Hyg, September 1, 2006; 75(3): 402 - 415.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
E. BOTTIEAU, J. CLERINX, E. VAN DEN ENDEN, M. VAN ESBROECK, R. COLEBUNDERS, A. VAN GOMPEL, and J. VAN DEN ENDE
Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center.
Am J Trop Med Hyg, July 1, 2006; 75(1): 133 - 138.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society of Tropical Medicine and Hygiene.